Evidence map›Paper›PMID 32219215›Full record

ArticleACS pharmacology & translational science2019

The Molecular Control of Calcitonin Receptor Signaling.

Emma Dal Maso, Alisa Glukhova, Yue Zhu, Javier Garcia-Nafria, Christopher G Tate, Silvia Atanasio, Christopher A Reynolds, Erney Ramírez-Aportela, Jose-Maria Carazo, Caroline A Hick and 8 more

Open access · greenAbstract read
In one paragraph

Article in ACS pharmacology & translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Calcitonin/PACTrends in pharmacological sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Capturing Peptide-GPCR Interactions and Their Dynamics.Molecules (Basel, Switzerland) · 2020
    Review
  16. Article
  17. Article
  18. A combined activation mechanism for the glucagon receptor.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Article
  20. Structure and Dynamics of Adrenomedullin Receptors AMACS pharmacology & translational science · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 6 countries.

Emma Dal MasoDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Alisa GlukhovaDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Yue ZhuThe National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Javier Garcia-NafriaMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, U.K.
Christopher G TateMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, U.K.
Silvia AtanasioSchool of Biological Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, U.K.
Christopher A ReynoldsSchool of Biological Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, U.K.
Erney Ramírez-AportelaBiocomputing Unit, National Center for Biotechnology (CNB-CSIC), C/Darwin, 3, Campus Universidad Autónoma, 28049 Cantoblanco, Madrid Spain.
Jose-Maria CarazoBiocomputing Unit, National Center for Biotechnology (CNB-CSIC), C/Darwin, 3, Campus Universidad Autónoma, 28049 Cantoblanco, Madrid Spain.
Caroline A HickDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Sebastian G B FurnessDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Debbie L HayThe University of Auckland, School of Biological Sciences, 3 Symonds Street, Auckland 1142, New Zealand.
Yi-Lynn LiangDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Laurence J MillerDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona 85259, United States.
Arthur ChristopoulosDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Ming-Wei WangThe National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Denise WoottenDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Patrick M SextonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria Australia.
Monash University · AUFudan University · CNCentro Nacional de Biotecnología · ESMRC Laboratory of Molecular Biology · GBUniversity of Essex · GBMayo Clinic in Arizona · USShanghai Institute of Materia Medica · CNUniversity of Auckland · NZ

Funding

Biotechnology and Biological Sciences Research Council BB/M006883/1Medical Research Council MC_U105197215
6 · The paper itself

Abstract

The calcitonin receptor (CTR) is a class B G protein-coupled receptor (GPCR) that responds to the peptide hormone calcitonin (CT). CTs are clinically approved for the treatment of bone diseases. We previously reported a 4.1 Å structure of the activated CTR bound to salmon CT (sCT) and heterotrimeric Gs protein by cryo-electron microscopy (Liang, Y.-L.,

Identifiers

PMID32219215
PMCPMC7088896
OpenAlexW2908839297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.